Direct-acting antivirals for HCV-related hepatocellular carcinoma reduces the risk of tumor progression - News-Medical.net

Direct-acting antivirals for HCV-related hepatocellular carcinoma reduces the risk of tumor progression - News-Medical.net
In a new cohort study of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), a disease with a high recurrence rate, researchers at the Osaka City University Graduate School of Medicine reported that after receiving cancer treatment, …
In a new cohort study of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), a disease with a high recurrence rate, researchers at the Osaka City University Graduate School … [+2670 chars] Read More



Related Stories

See All